The current valuation score of Enanta Pharmaceuticals Inc is 7.10, ranking 124 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -4.86, which is -80.68% below the recent high of -0.94 and -92.96% above the recent low of -9.37.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.